ArriVent Biopharma Stock

arrivent.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $260MM

ArriVent Biopharma is a drug development platform that sources oncology therapies from around the world and drives them through the approval process.

Register To Buy and Sell Shares

For more details on financing and valuation for ArriVent Biopharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access ArriVent Biopharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ArriVent Biopharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About ArriVent Biopharma’s Stock

Can you buy ArriVent Biopharma stock?
ArriVent Biopharma is not publicly traded on NYSE or NASDAQ in the U.S. To buy ArriVent Biopharma stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell ArriVent Biopharma stock?
Yes, you can sell stock of a private company like ArriVent Biopharma. Forge can help you sell your ArriVent Biopharma stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is ArriVent Biopharma’s stock price?
ArriVent Biopharma is a privately held company and therefore does not have a public stock price. However, you may access ArriVent Biopharma’s private market stock price with Forge Data.
What is ArriVent Biopharma’s stock ticker symbol?
ArriVent Biopharma does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Nov 28, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.